[1]
J. Bartkowiak-Wieczorek, “Maturation, pharmacogenomics and metabolomics as factors determining pharmacokinetic and pharmacodynamics profile of alpha-agonist in pediatric intensive care unit patients”, JMS, vol. 85, no. 3, pp. 219–222, Sep. 2016, doi: 10.20883/jms.2016.147.